Last reviewed · How we verify

NCT04820738

Effects of Sensory Motor Training on Balance and Proprioception Among Post-Menopausal Obese Women

Completed NA Last updated 30 March 2021
What this trial tests

NA trial testing Sensorimotor training exercises in Post Menopaused Female in 44 participants. Completed in 20 December 2020.

Timeline
15 February 2020
Primary endpoint
20 October 2020
20 December 2020

Quick facts

Lead sponsorRiphah International University
PhaseNA
StatusCompleted
Study typeINTERVENTIONAL
Allocationrandomized
Designparallel
Maskingsingle
Primary purposetreatment
Enrollment44
Start date15 February 2020
Primary completion20 October 2020
Estimated completion20 December 2020
Sites1 location across Pakistan

Drugs / interventions tested

Conditions studied

Sponsor

Riphah International University

Who can join

Adults 45 to 65, female only, with Post Menopaused Female. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

Postmenopausal obese women often have difficulties with balance and proprioception. Sensorimotor training is an important part of physical therapy interventions, with emerging evidence that it could be beneficial for postmenopausal obese women. Objective: To find the impact of sensorimotor training on balance and proprioception among postmenopausal obese women.

Publications & conference data

1 peer-reviewed publication reference this trial (live from Europe PMC):

  1. Medicinal plants for the treatment and prevention of post-menopausal obesity: a review.
    Liu J, Akter R, Rupa EJ, Van-An H, et al · · 2025 · cited 1× · PMID 40469982 · DOI 10.3389/fphar.2025.1564131

Verify or expand the search:

Other Riphah International University trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT04820738.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing